Monday, August 12, 2019

Natco Pharma gets 6 observations from USFDA for API Facility

At the end of the inspection, the Mekaguda facility, near Hyderabad received six observations mostly procedural in nature.

from India Infoline News Service https://ift.tt/2YUFmIh
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)